Hyperinsulinemia
Showing 1 - 25 of 456
Hyperinsulinemia, PreDiabetes Trial in Basel (Anakinra, Placebo)
Not yet recruiting
- Hyperinsulinemia
- PreDiabetes
- Anakinra
- Placebo
-
Basel, SwitzerlandUniversity Hospital Basel
May 2, 2023
Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced Trial in Haifa (Pioglitazone)
Recruiting
- Metastatic Breast Cancer
- +2 more
-
Haifa, IsraelRambam Health Care Campus
Feb 22, 2023
Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in New York (Diazoxide oral suspension, 1 mg per
Recruiting
- Hyperinsulinemia
- +3 more
- Diazoxide oral suspension, 1 mg per kg per dose
- +3 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 6, 2023
Insulin Resistance, Hyperinsulinism, Immune System Trial in Nîmes (Blood test)
Recruiting
- Insulin Resistance
- +2 more
- Blood test
-
Nîmes, Gard, France
- +1 more
Sep 23, 2022
Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)
Recruiting
- Insulin Resistance
- +4 more
- Insulin human
- +8 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 2, 2023
Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)
Not yet recruiting
- Breast Cancer
- +2 more
- Dapagliflozin 10mg
-
New Haven, ConnecticutYale Cancer Center Smilow Cancer Hospital
Aug 3, 2023
PCOS, Hyperinsulinemia, Insulin Resistance Trial in Dublin (Time restricted eating, Normal ad libitum diet)
Recruiting
- PCOS
- +2 more
- Time restricted eating
- Normal ad libitum diet
-
Dublin, Leinster, IrelandRobert Graves Institute of Endocrinology, Tallaght University Ho
Sep 15, 2022
Gynecology Trial in Houston (drug, other, procedure, behavioral)
Active, not recruiting
- Gynecology
- Metformin
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 14, 2022
Octreotide in the Treatment of Congenital Hyperinsulinemia
Completed
- Congenital Hyperinsulinaemic Hypoglycaemia
- Octreotide Adverse Reaction
- Octreotide Injection
-
Beijing, Beijing, ChinaDepartment of Endocrinology, Genetics, Metabolism
Dec 19, 2021
Insulin Resistance, Hyperinsulinemia, Dyslipidemias Trial in New York (drug, device, diagnostic test, dietary supplement)
Recruiting
- Insulin Resistance
- +2 more
- Alpelisib 150 mg [Piqray], 2 overencapsulated tablets (total: 300 mg)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 3, 2023
Primary Aldosteronism in Blacks
Recruiting
- Adrenal Gland Neoplasm
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Obesity, Infertility, Hypogonadotropic Hypogonadotropism Trial in Aurora (Insulin, Intralipid, Dextrose)
Completed
- Obesity
- +3 more
- Insulin
- +5 more
-
Aurora, ColoradoUniversity of Colorado Denver
Jan 12, 2022
Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,
Not yet recruiting
- Insulin Resistance
- +3 more
- Insulin human
- +11 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 6, 2023
Diabetes, Type 1 Trial in Nashville (Standard Carb Diet, Low Carb Diet)
Recruiting
- Diabetes Mellitus, Type 1
- Standard Carb Diet
- Low Carb Diet
-
Nashville, TennesseeVanderbilt University Medical Center
Sep 17, 2021
Diet Modification, Insulin Resistance, Hyperinsulinemia Trial in Kelowna (Dietary intervention)
Recruiting
- Diet Modification
- +2 more
- Dietary intervention
-
Kelowna, British Columbia, CanadaUniversity of British Columbia Okanagan
Sep 27, 2021
Sedentary Lifestyle, Hyperinsulinemia, Glucose Tolerance Impaired Trial in Houston (Muscular Exercise)
Active, not recruiting
- Sedentary Lifestyle
- +7 more
- Muscular Exercise
-
Houston, TexasUniversity of Houston
Nov 19, 2021
Insulin Resistance, Hyperglycemia, Hyperinsulinemia Trial in Xi'an (Selective Cold, Electroacupuncture)
Completed
- Insulin Resistance
- +4 more
- Selective Cold
- Electroacupuncture
-
Xi'an, Shanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Apr 29, 2020
Overweight and Obesity, Insulin Resistance, Metabolic Disease Trial in Corvallis (Hyperinsulinemic-euglycemic Clamp)
Terminated
- Overweight and Obesity
- +4 more
- Hyperinsulinemic-euglycemic Clamp
-
Corvallis, OregonOregon State University
Jun 7, 2022
Hyperinsulinism, Insulin Resistance, Insulin Sensitivity Trial (Vigabatrin Pill, Placebo oral tablet)
Unknown status
- Hyperinsulinism
- +4 more
- Vigabatrin Pill
- Placebo oral tablet
- (no location specified)
Aug 16, 2019
Polycystic Ovary Syndrome Trial in Shenyang (Canagliflozin combined with metformin, metformin)
Completed
- Polycystic Ovary Syndrome
- Canagliflozin combined with metformin
- metformin
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Apr 13, 2022
Aerobic Capacity and Physical Fitness Level of PCOS
Recruiting
- Polycystic Ovary Syndrome
-
Ankara, TurkeyHacettepe University
Aug 6, 2022
Type 1 Diabetes, Maturity-Onset Diabetes of the Young, Type 2, MODY2 Trial in Nashville (Hyperinsulinemic, euglycemic clamp, 20%
Completed
- Type 1 Diabetes Mellitus
- +3 more
- Hyperinsulinemic, euglycemic clamp
- 20% dextrose
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 29, 2019
PCO Trial in Peshawar (OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD), Metformin (1000 mg Twice a day))
Recruiting
- PCO
- OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD)
- Metformin (1000 mg Twice a day)
-
Peshawar, Khyber Pakhtunkhwa, PakistanGynecology and Obstetric, Hayatabad Medical Complex
Jul 19, 2023
Type1diabetes, Hypoglycemia, Hypoglycemia Unawareness Trial in Philadelphia (Phentolamine, Propranolol, Placebo)
Active, not recruiting
- Type1diabetes
- +3 more
- Phentolamine
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania - Institute for Diabetes, Obesity and
Mar 3, 2022